Trial intelligence / Profile preview

Bioequivalence of Tansulosine 0.4 mg in Healthy Subjects (Fed State)

NCT01338623Phase 4Unknown

Start
Apr 2011
Primary completion
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tamsulosin in benign prostatic hyperplasia (BPH). Status: unknown.

02

Drugs

tamsulosin
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on NCT01338623.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01338623.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call